1
|
Hong L, Hongmei W, Leijie X, Dandan Z, Peng L, Zhifei H, Ruimin M, Yijun S, Guanghui Z, Guojun Z. Serum ceramide concentrations are associated with depression in patients after ischemic stroke-A two-center case-controlled study. Clin Chim Acta 2021; 518:110-115. [PMID: 33775701 DOI: 10.1016/j.cca.2021.03.014] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2020] [Revised: 03/10/2021] [Accepted: 03/11/2021] [Indexed: 10/21/2022]
Abstract
BACKGROUND AND AIMS The present study aims to correlate the severity of post-stroke depression (PSD) and serum ceramide concentration. MATERIALS AND METHODS In this two-center case-control study, we prospectively collected clinical and demographical information from age and gender-matched 51 PSD patients, 56 non-post-stroke depression (Non-PSD) patients, and 39 patients with major depression (MD) to perform the suitable biochemical analysis to bring a correlation in causing depression in patients soon after the stroke. The ROC curve method was used to evaluate ceramide's diagnostic efficacy in all three groups of patients. A follow-up analysis was also conducted based on PSD severity to associate serum ceramide levels and neuropsychiatric symptoms. The severity of the patient's depressive symptoms was assessed by using the self-rating depression scale (SDS). RESULTS In comparison between PSD and MD patients, three serum ceramide species were found to be significantly different. Compared with Non-PSD patients, PSD patients had significantly higher levels of all the four serum ceramides, and increasing levels ofC16:0, C18:0(VS MD) and C16: 0(VS Non-PSD) serve as a diagnostic tool and an independent risk factor in all three categories of patients. Moreover, the follow-up analysis results showed that, as the treatment progressed, the differences in the 3 serum ceramide species were statistically significant. CONCLUSION There was a stage-specific association between serum ceramides and PSD, and the potential pathophysiological mechanism has to be investigated in future research.
Collapse
Affiliation(s)
- Lv Hong
- Clinical Diagnosis Department of Beijing Tiantan Hospital & Capital Medical University, China; NMPA Key Laboratory for Quality Control of In Vitro Diagnostics, Fengtai district, Beijing, 100076, China; Beijing Engineering Research Center of Immunological Reagents Clinical Research, Fengtai district, Beijing, 100076, China
| | - Wang Hongmei
- Clinical Diagnosis Department of Beijing Rehabilitation Hospital & Capital Medical University, China
| | - Xie Leijie
- Hangzhou BIOZON Medical Laboratory Co. LTD, Hangzhou, Zhejiang, China
| | - Zou Dandan
- Hangzhou BIOZON Medical Laboratory Co. LTD, Hangzhou, Zhejiang, China
| | - Liu Peng
- Hangzhou BIOZON Medical Laboratory Co. LTD, Hangzhou, Zhejiang, China
| | - Hu Zhifei
- Hangzhou BIOZON Medical Laboratory Co. LTD, Hangzhou, Zhejiang, China
| | - Ma Ruimin
- Clinical Diagnosis Department of Beijing Tiantan Hospital & Capital Medical University, China; NMPA Key Laboratory for Quality Control of In Vitro Diagnostics, Fengtai district, Beijing, 100076, China; Beijing Engineering Research Center of Immunological Reagents Clinical Research, Fengtai district, Beijing, 100076, China
| | - Shi Yijun
- Clinical Diagnosis Department of Beijing Tiantan Hospital & Capital Medical University, China
| | - Zheng Guanghui
- Clinical Diagnosis Department of Beijing Tiantan Hospital & Capital Medical University, China; NMPA Key Laboratory for Quality Control of In Vitro Diagnostics, Fengtai district, Beijing, 100076, China; Beijing Engineering Research Center of Immunological Reagents Clinical Research, Fengtai district, Beijing, 100076, China.
| | - Zhang Guojun
- Clinical Diagnosis Department of Beijing Tiantan Hospital & Capital Medical University, China; NMPA Key Laboratory for Quality Control of In Vitro Diagnostics, Fengtai district, Beijing, 100076, China; Beijing Engineering Research Center of Immunological Reagents Clinical Research, Fengtai district, Beijing, 100076, China.
| |
Collapse
|